Profiles for drugs starting with 'r'
✉ Email this page to a colleague
US Patents and Regulatory Information for r
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal | RISPERIDONE | risperidone | POWDER;INTRAMUSCULAR | 218586-001 | Sep 2, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Madrigal | REZDIFFRA | resmetirom | TABLET;ORAL | 217785-003 | Mar 14, 2024 | RX | Yes | Yes | 11,986,481 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Accord Hlthcare | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 206434-002 | Oct 31, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
